BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16371044)

  • 1. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation.
    Martin-Henao GA; Torrico C; Azqueta C; Amill B; Querol S; Garcia J
    Transfusion; 2005 Dec; 45(12):1917-24. PubMed ID: 16371044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
    Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK; Kaufman J
    Transfusion; 2007 Apr; 47(4):629-35. PubMed ID: 17381621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
    Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
    Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight refrigerator storage of autologous peripheral progenitor stem cells without cryopreservation.
    Donmez A; Cagirgan S; Saydam G; Tombuloglu M
    Transfus Apher Sci; 2007 Jun; 36(3):313-9. PubMed ID: 17569591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
    Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
    Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
    Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thawing of cryopreserved hematopoietic progenitor cells from apheresis with a new dry-warming device.
    Triana E; Ortega S; Azqueta C; Pomares H; Valdivia E; Duarte R; Massuet L; Martín-Henao GA
    Transfusion; 2013 Jan; 53(1):85-90. PubMed ID: 22536847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient method for the cryopreservation of fetal human liver hematopoeitic progenitor cells.
    Zhao J; Hao HN; Thomas RL; Lyman WD
    Stem Cells; 2001; 19(3):212-8. PubMed ID: 11359946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
    Laroche V; McKenna DH; Moroff G; Schierman T; Kadidlo D; McCullough J
    Transfusion; 2005 Dec; 45(12):1909-16. PubMed ID: 16371043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
    Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
    Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function.
    Cabezudo E; Dalmases C; Ruz M; Sanchez JA; Torrico C; Sola C; Querol S; García J
    Transfusion; 2000 Oct; 40(10):1223-7. PubMed ID: 11061859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.
    Sartor M; Antonenas V; Garvin F; Webb M; Bradstock KF
    Bone Marrow Transplant; 2005 Aug; 36(3):199-204. PubMed ID: 15937512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.